Amsurg Corp. (NASDAQ:AMSG) shares were down 2.6% during trading on Thursday . The company traded as low as $69.93 and last traded at $70.46, with a volume of 1,060,369 shares changing hands. The stock had previously closed at $72.31.

A number of research analysts have commented on AMSG shares. Mizuho raised their target price on shares of Amsurg Corp. from $84.00 to $90.00 and gave the company a “buy” rating in a research report on Wednesday, May 4th. Jefferies Group reissued a “buy” rating and set a $96.00 target price on shares of Amsurg Corp. in a research report on Thursday, May 5th. Robert W. Baird reissued a “buy” rating on shares of Amsurg Corp. in a research report on Monday, May 16th. Barclays PLC started coverage on shares of Amsurg Corp. in a research report on Wednesday, June 1st. They set an “equal weight” rating and a $85.00 target price on the stock. Finally, Wells Fargo & Co. started coverage on shares of Amsurg Corp. in a research report on Tuesday, June 14th. They issued a “market perform” rating on the stock. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $93.91.

The company has a market capitalization of $3.85 billion and a P/E ratio of 20.86. The company has a 50 day moving average price of $77.42 and a 200-day moving average price of $74.55.

Amsurg Corp. (NASDAQ:AMSG) last posted its earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, beating the Zacks’ consensus estimate of $1.08 by $0.02. The company earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. The company’s quarterly revenue was up 21.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.97 EPS. On average, equities analysts anticipate that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.

Several hedge funds have modified their holdings of AMSG. KBC Group NV boosted its stake in shares of Amsurg Corp. by 59.0% in the fourth quarter. KBC Group NV now owns 13,997 shares of the company’s stock valued at $1,064,000 after buying an additional 5,193 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in shares of Amsurg Corp. during the fourth quarter valued at about $1,189,000. MSF Capital LLC boosted its stake in shares of Amsurg Corp. by 584.6% in the fourth quarter. MSF Capital LLC now owns 21,176 shares of the company’s stock valued at $1,609,000 after buying an additional 18,083 shares in the last quarter. US Bancorp DE boosted its stake in shares of Amsurg Corp. by 30.5% in the fourth quarter. US Bancorp DE now owns 23,339 shares of the company’s stock valued at $1,774,000 after buying an additional 5,461 shares in the last quarter. Finally, Deere & Co. boosted its stake in shares of Amsurg Corp. by 4.7% in the fourth quarter. Deere & Co. now owns 23,613 shares of the company’s stock valued at $1,795,000 after buying an additional 1,069 shares in the last quarter.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.